Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04452461 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery

Study acronym: PANCREAS
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 10, 2024 (before its estimated December 12, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: May 1, 2024 to Dec 12, 2025
    • Site contact updated
    v5
  2. Study title shortened, about 6 wordsv4
  3. Primary completion date: May 1, 2022 to May 1, 2024
    • Interventions: Gemcitabine / Nab-paclitaxel (Drug), Stereotactic body radiation therapy (Radiation), mFOLFIRINOX (Drug) to Gemcitabine / Nab-paclitaxel (Drug), mFOLFIRINOX (Drug)
    • Site contact updated
    • Study description shortened, about 4 words
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2020 to Mar 1, 2021
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single-arm, single-center feasibility trial of patients with borderline resectable pancreatic adenocarcinoma receiving chemotherapy with mFOLFIRINOX or gemcitabine / nab-paclitaxel followed by pancreatectomy.
Trial Details
NCT Number NCT04452461
Lead Sponsor Hamilton Health Sciences Corporation
Conditions
(from sponsor)		 Pancreatic Adenocarcinoma
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov